Patterns of PET/CT-assessed bone-marrow involvement and prognosis in newly diagnosed Hodgkin lymphoma: a detailed review of 122 treated patients treated with ABVD

Zwarthoed Cholette; Ouvier Matthieu John; Borra Anna; Bergesio Fabrizio; Chauvie Stephane; Biggi Alberto; Hutchings Martin; El-Galaly Tarek; Gallamini Andrea

首页> 外文期刊>Leukemia and lymphoma >Patterns of PET/CT-assessed bone-marrow involvement and prognosis in newly diagnosed Hodgkin lymphoma: a detailed review of 122 treated patients treated with ABVD

【24h】

Patterns of PET/CT-assessed bone-marrow involvement and prognosis in newly diagnosed Hodgkin lymphoma: a detailed review of 122 treated patients treated with ABVD

机译：新诊断霍奇金淋巴瘤中PET / CT评估的骨髓受累和预后的模式：对122例接受ABVD治疗的患者的详细综述

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia and lymphoma》 |2015年第5期|共1页
作者
Zwarthoed Cholette; Ouvier Matthieu John; Borra Anna; Bergesio Fabrizio; Chauvie Stephane; Biggi Alberto; Hutchings Martin; El-Galaly Tarek; Gallamini Andrea;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Patterns of PET/CT-assessed bone-marrow involvement and prognosis in newly diagnosed Hodgkin lymphoma: a detailed review of 122 treated patients treated with ABVD [J] . Zwarthoed Cholette, Ouvier Matthieu John, Borra Anna, Leukemia and lymphoma . 2015,第5期

机译：新诊断霍奇金淋巴瘤中PET / CT评估的骨髓受累和预后的模式：对122例接受ABVD治疗的患者的详细综述
2. Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) and Lymphocyte to Monocyte Ratio (LMR) in Newly Diagnosed Advanced-Stage Hodgkin Lymphoma Patients Treated up-Front with a PET-2 Risk Adapted Protocol [J] . Romano Alessandra, Di Raimondo Francesco, Pavoni Chiara, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：新诊断的晚期阶段霍奇金淋巴瘤患者中嗜中性粒细胞与淋巴细胞比（NLR）和淋巴细胞与单核细胞比（LMR）的预后相关性，用PET-2风险适应方案治疗
3. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy [J] . Romano Alessandra, Parrinello Nunziatina Laura, Vetro Calogero, Annals of hematology . 2018,第6期

机译：新诊断霍奇金淋巴瘤患者中嗜中性粒细胞比（NLR）和淋巴细胞对单核细胞淋巴瘤（LMR）对肝脏淋巴瘤患者的预后含义及其基于PET-2的策略
4. PET WITH ~(18)FDG AND SPECT WITH ~(99)Tc~m-SESTAMIBI FOR THERAPY MANAGEMENT IN PATIENTS WITH TREATED MALIGNANT LYMPHOMAS [C] . L.G. STRAUSS, A. DIMITRAKOPOULOU-STRAUSS, H. GOLDSCHMIDT, Tomography in nuclear medicine . 1995

机译：含〜（18）FDG的PET和含〜（99）Tc〜m-SESTAMIBI的SPECT用于治疗恶性淋巴瘤的患者的治疗
5. Estimation of G-CSF effectiveness in reducing neutropenia hospitalization among Non-Hodgkin's Lymphoma (NHL) patients treated with anthracycline-based chemotherapy. [D] . Pan, Xiaoyun. 2010

机译：估计G-CSF在以蒽环类为基础的化学疗法治疗的非霍奇金淋巴瘤（NHL）患者中减少中性粒细胞减少症住院的有效性。
6. Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma [O] . Anas Younes, Yasuhiro Oki, Peter McLaughlin, -1

机译：利妥昔单抗联合ABVD在新诊断的经典霍奇金淋巴瘤患者中的2期研究
7. EP-1341: Patterns of relapse in PET staged advanced Hodgkin lymphoma treated with ABVD chemotherapy [O] . Lapuz C., Capp A., OBrien P., 2015

机译：EP-1341：ABVD化疗治疗的PET分期晚期霍奇金淋巴瘤的复发模式

Patterns of PET/CT-assessed bone-marrow involvement and prognosis in newly diagnosed Hodgkin lymphoma: a detailed review of 122 treated patients treated with ABVD

著录项

相似文献

相关主题

期刊订阅